Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Copeptin in Aortic Valve Replacement (CARE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier:
NCT01648647
First received: July 20, 2012
Last updated: NA
Last verified: July 2012
History: No changes posted

July 20, 2012
July 20, 2012
May 2012
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Copeptin in Aortic Valve Replacement
GE DHM-AN-OR-2012/01

Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients scheduled for surgical or transcatheter aortic valve replacement

Copeptin in Patients Undergoing Aortic Valve Replacement
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
Not Provided
Not Provided

Inclusion Criteria:

  • Patients undergoing surgical aortic valve replacment
  • Patients undergoing transcatheter aortic valve replacment

Exclusion Criteria:

  • denial by patient
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01648647
GE DHM-AN-OR-2012/01
No
Deutsches Herzzentrum Muenchen
Deutsches Herzzentrum Muenchen
Not Provided
Not Provided
Deutsches Herzzentrum Muenchen
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP